Tolerance and efficacy of the mars system in patients with severe alcoholic hepatitis non-responder to steroids: A pilot study

被引：0
|
作者：
Boitard, Jeanne
Louvet, Alexandre
Bismuth, Benjamin
Dharancy, Sebastien
Wartel, Faustine
Canva, Valerie
Deltenre, Pierre
Jude, Brigitte
Fourrier, Francois
Mathurin, Philippe
机构：
[1] Ctr Hosp Reg & Univ Lille, Hop Huriez, F-59037 Lille, France
[2] INSERM, U 795, F-59037 Lille, France
[3] Hop Cardiol, F-59037 Lille, France
[4] Hop Salengro, Lille, France
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
202
引用
收藏
页码：327A / 327A
页数：1
相关论文
共 50 条
  • [31] INFECTION IS COMMON IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS TREATED WITH STEROIDS BUT NOT ASSOCIATED WITH POOR OUTCOME
    Dhanda, A.
    Collins, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S228 - S228
  • [32] BASELINE LIVER BIOPSY CAN PREDICT RESPONSE TO STEROIDS IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS
    Shasthry, S. M.
    Rastogi, A.
    Bhadoria, A. S.
    Vashishtha, C.
    Kumar, M.
    Sarin, S. K.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S176 - S176
  • [33] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients
    Bernstein, DE
    Jeffers, LJ
    Lake-Bakaar, G
    Reddy, KR
    Schiff, ER
    GASTROENTEROLOGY, 1999, 116 (04) : A1190 - A1190
  • [34] Clinical outcome of patients with severe alcoholic hepatitis (AH) responders (R) and non responders (NR) to steroids: the Geneva experience
    Ramer, L.
    Goossens, N.
    Ongaro, M.
    Magini, G.
    Spahr, L.
    SWISS MEDICAL WEEKLY, 2022, 152 : 22S - 22S
  • [35] A pilot study to determine the efficacy and safety of ribavirin in patients of acute severe hepatitis E
    Gupta, Rahul
    Sidhu, Sandeep S.
    Mehta, Varun
    Sood, Ajit
    HEPATOLOGY, 2014, 60 : 562A - 562A
  • [36] IDENTIFICATION OF THE THERAPEUTIC WINDOW FOR USE OF STEROIDS IN SEVERE ALCOHOLIC HEPATITIS: A LARGE GLOBAL STUDY
    Pablo Arab, Juan
    Baeza, Natalia
    Antonio Diaz, Luis
    Javier Idalsoaga, Francisco
    Morales Arraez, Dalia
    Ventura-Cots, Meritxell
    Zhang, Wei
    Ahn, Joseph
    Simonetto, Douglas A.
    Mehta, Tej
    Stefanescu, Horia
    Horhat, Adelina
    Bumbu, Andreea
    Dunn, Winston
    Attar, Bashar M.
    Agrawal, Rohit
    Cabezas, Joaquin
    Parker, Richard
    Sans, Maria Poca
    Pastor, German Soriano
    Sarin, Shiv Kumar
    Maiwall, Rakhi
    Jalal, Prasun K.
    Abdulsada, Saba
    De La Tijera, Maria Higuera
    Kulkarni, Anand V.
    Salazar, Patricia Guerra
    Skladany, Lubomir
    Bystrianska, Natalia
    Gonzalez, Veronica Enith Prado
    Clemente, Ana
    Rincon, Diego
    Haider, Tehseen
    Cairo, Fernando, Sr.
    Cohelo, Marcela De Sousa
    Romero, Gustavo
    Pollarsky, Florencia
    Restrepo, Juan Carlos
    Rendon, Luis Guillermo Toro
    Yaquich, Pamela
    Mendizabal, Manuel
    Garrido, Maria Laura
    Marciano, Sebastian
    Bessone, Fernando Oscar
    Marcelo, Julio Santiago
    Piombino, Diego
    Dirchwolf, Melisa
    Arancibia, Juan Pablo
    Altamirano, Jose
    Kim, Won
    HEPATOLOGY, 2020, 72 : 170A - 172A
  • [37] Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients
    Provazzi P.J.S.
    Arcuri H.A.
    De Carvalho-Mello I.M.V.G.
    Pinho J.R.R.
    Nogueira M.L.
    Palma M.S.
    Rahal P.
    BMC Research Notes, 3 (1)
  • [38] Retreatment of IFN/ribavirin non-responder hepatitis C patients: Benefit of PEG-interferon/ribavirin amantadine.
    Maynard, M
    Ahmed, SNS
    Bailly, F
    Rozier, F
    Benmakhlouf, N
    Bourne-Branchu, V
    Fazly, T
    Nemoz, C
    Adeleine, P
    Pradat, P
    Trepo, C
    HEPATOLOGY, 2004, 40 (04) : 398A - 398A
  • [39] A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis
    Menon, KVN
    Stadheim, L
    Kamath, PS
    Wiesner, RH
    Gores, GJ
    Peine, CJ
    Shah, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02): : 255 - 260
  • [40] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Oguz, Dilek
    Cicek, Bahattin
    Filik, Levent
    Odemis, Bulent
    Kilic, Mesut
    Altintas, Engin
    Zengin, Neslihan
    Altiparmak, Emin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (04) : 580 - 583
12345